|
|
GW6471(E 式)
|
880635-03-0
|
|
VH-298
|
|
2097381-85-4
|
|
（Empesertib ） BAY1161909
|
|
1443763-60-7
|
|
GSK621
|
|
1346607-05-3
|
|
NVP-2
|
|
1263373-43-8
|
|
Rogaratinib（BAY1163877）
|
|
1443530-05-9
|
|
AP20187
|
|
195514-80-8
|
|
CD38
|
|
1700637-55-3
|
|
THAL-SNS-032
|
|
2139287-33-3
|
|
CPI-0610
|
|
1380087-89-7
|
|
ACBI- 1
|
|
2375564-55-7
|
|
Azido-PEG4-amine
|
|
951671-92-4
|
|
Azido-PEG5-amine
|
|
516493-93-9
|
|
Azido-PEG6-amine
|
|
957486-82-7
|
|
Azido-PEG3-acid
|
|
1056024-94-2
|
|
Azido-PEG4-acid
|
|
1257063-35-6
|
|
Azido-PEG6-acid
|
|
361189-66-4
|
|
Azido-PEG8-acid
|
|
1214319-92-2
|
|
m-PEG4-azide
|
|
606130-90-9
|
|
6-Azido-hexanoic acid
|
1-叠氮基金刚烷
|
24886-73-5
|
|
GXV813
|
|
2640099-21-2
|
|
NS 11021
|
|
956014-19-0
|
|
NS 5806
|
|
426834-69-7
|
|
Tazemetostat HBr
|
|
1467052-75-0
|
|
4H-1-Benzopyran-4-one,7-(dimethylamino)-2-phenyl-
|
|
93315-70-9
|
|
MST-312
|
|
368449-04-1
|
|
Labuxtinib
|
|
1426449-01-5
|
|
BL-1249
|
|
18200-13-0
|
|
TH-Z93
|
|
2260887-09-8
|
|
7-methyloctanoic acid
|
|
693-19-6
|
|
Razuprotafib
|
|
1008510-37-9
|
|
SMER3
|
|
67200-34-4
|
|
PRI-724
|
|
1198780-43-6
|
|
NS-3736
|
|
265646-94-4
|
|
NS 3728
|
|
265646-85-3
|
|
BIS-TRIS
|
|
6976-37-0
|
|
Flav7
|
|
00-00-0
|
|
1-azido-2-methylbenzene
|
|
31656-92-5
|
|
|
3-叠氮丙胺/盐酸盐
|
70017-54-8
|
|
Phenyl azide
|
|
622-37-7
|
|
BENZYL AZIDE
|
|
622-79-7
|
|
AzidoMethyl Phenyl Sulfide
|
|
77422-70-9
|
|
4-Azidotoluene solution
|
|
2101-86-2
|
|
Benzoyl azide, 4-acetyl-
|
|
114691-91-7
|
|
1-azido-4-methoxybenzene
|
|
2101-87-3
|
|
1-azido-4-chlorobenzene
|
|
3296-05-7
|
|
1-AZIDO-4-BROMOBENZENE
|
|
2101-88-4
|
|
3-(Azidomethyl)pyridine
|
|
864528-33-6
|
|
7-Azido-4-methylcoumarin
|
|
95633-27-5
|
|
|
1-叠氮基-4-氟苯 溶液
|
3296-02-4
|
|
N-(4-Azido-2-nitrophenyl)-2-aminoethylsulfonate, Sodium Salt, Dihydrate
|
|
352000-05-6
|
|
CD38 inhibitor 2
|
|
2597933-78-1
|
|
1-(4-fluorophenyl)-1H-indole-5-carboxylic acid
|
1-(4-氟苯基)-1H-吲哚-5-羧酸
|
243467-60-9
|
|
Roniciclib
|
|
1223498-69-8
|
|
2-(2H-Tetrazol-5-yl)-ethanol
|
2-(2H-四唑-5-基)-乙醇
|
17587-08-5
|
|
2-(5-Tetrazolyl)ethanamine Hydrochloride
|
2-(5-四唑基)乙胺盐酸盐
|
33841-57-5
|
|
2-(Methylamino)isobutyric acid
|
2-(甲氨基)异丁酸水合物
|
2566-34-9
|
|
3-bromo-5-methylimidazole
|
3-溴-5-甲基异唑
|
25741-97-3
|
|
FXIa-IN-7
|
|
2488952-56-1
|
|
1,3,5-Tris(3-Sulfanylpropyl)-1,3,5-Triazinane-2,4,6-Trione
|
|
78366-85-5
|
|
IAG933
|
|
2714434-21-4
|
|
1-Azido-2-(4-hydroxyphenyl)ethane
|
|
74447-34-0
|
|
EICOSAPENTAENOICACIDETHYLESTER(EPAEE)(AS)
|
|
73310-10-8
|
|
Ethyl docosa-4,7,10,13,16,19-hexaenoate
|
|
84494-72-4
|
|
N3-C5-NHSeste
|
|
866363-70-4
|
|
Altiratinib
|
|
1345847-93-9
|
|
2-(2-Azidoacetamido)acetic acid
|
|
855750-87-7
|
|
N3-Gly-Gly-OH (DCHA)
|
|
2706488-76-6
|
|
N3-PEG6-OH
|
|
86770-69-6
|
|
N3-PEG5-OH
|
|
86770-68-5
|
|
N3-PEG4-OH
|
|
86770-67-4
|
|
N3-PEG3-OH
|
|
86520-52-7
|
|
N3-PEG2-OH
|
|
139115-90-5
|
|
Azido-PEG1-CH2CO2H
|
|
79598-48-4
|
|
Azido-PEG2-CH2CO2H
|
|
882518-90-3
|
|
Azido-PEG3-CH2CO2H
|
|
172531-37-2
|
|
Azido-PEG4-CH2CO2H
|
|
201467-81-4
|
|
AZIDO-PEG4-AZIDE
|
|
182760-73-2
|
|
1,2-diazidoethane
|
|
629-13-0
|
|
AZIDO-PEG1-AZIDE
|
|
59559-06-7
|
|
1,5-Diazido-3-oxapentane
|
|
24345-74-2
|
|
Azido-PEG3-azide
|
|
101187-39-7
|
|
Azido-PEG5-Azide
|
|
356046-26-9
|
|
N3-S-S-N3
|
|
352305-38-5
|
|
N3-PEG1-COOH
|
|
1393330-34-1
|
|
Azido-PEG2-C2-acid
|
|
1312309-63-9
|
|
Benzenemethanol, 4-(1,2,4,5-tetrazin-3-yl)-
|
|
1225146-54-2
|
|
|
(4-(1,2,4,5-四嗪-3-基)苯基)甲胺
|
1092689-33-2
|
|
|
4-(1,2,4,5-四嗪-3-基)苯甲酸
|
1345866-65-0
|
|
2-(4-(1,2,4,5-tetrazin-3-yl)phenyl)acetic acid
|
|
1380500-92-4
|
|
|
四螨嗪
|
74115-24-5
|
|
3-(p-Hydroxyphenyl)-s-tetrazin
|
|
58884-34-7
|
|
|
4-(6-甲基-1,2,4,5-四嗪-3-基)苯酚
|
58884-35-8
|
|
(4-(6-methyl-1,2,4,5-tetrazin-3-yl)phenyl)methanamine
|
|
1345955-28-3
|
|
|
(4-(6-甲基-1,2,4,5-四嗪-3-基)苯基)甲醇
|
1380500-87-7
|
|
4-(6-methyl-1,2,4,5-tetrazin-3-yl)benzoic acid
|
|
1345866-66-1
|
|
2-[4-(6-methyl-1,2,4,5-tetrazine-3-yl)phenyl]acetic acid
|
|
1380500-88-8
|
|
Iptacopan hydrochloride hydrate
|
|
2447007-60-3
|
|
HEPES
|
|
7365-45-9
|
|
PIPES
|
|
5625-37-6
|